Biotechnology

Filter

Current filters:

None

Popular Filters

1950 to 1974 of 2289 results

GSK settles with Genentech over ofatumumab patents

28-03-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

Panacea Biotech inaugurates new cancer drug facility in India

28-03-2012

Indian health care management company Panacea Biotec says that it has inaugurated a new state-of-the-art…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPanacea Biotec

EMA and HMA agree common approach on commercially confidential info and personal data

27-03-2012

Following recent meetings, the Heads of Medicines Agencies and the European Medicines Agency yesterday…

BiotechnologyEuropePharmaceuticalRegulationResearch

European governments must ensure R&D is converted into new businesses, new products

27-03-2012

National governments in Europe need to do more to ensure that R&D innovation in the biotech industry…

BiotechnologyEuropeFinancialRegulationResearch

Recalls threaten public confidence in vaccines and immunoglobulins

27-03-2012

Quality defects and donor tissue history must be more carefully monitored to increase public acceptance…

BiotechnologyHealthcareImmunologicalsRegulationVaccines

Pharming in deal with Hyupjin for Ruconest in South Korea

27-03-2012

Dutch biotech firm Pharming Group (NYSE Euronext: PHARM) has entered into an agreement with Seoul-based…

Asia-PacificBiotechnologyHyupjin CorpLicensingPharmingRare diseasesRhucinRuconest

EMA strengthens policies on handling of conflicts of interest

26-03-2012

The European Medicines Agency says that, following its implementation in September 2011, the Management…

BiotechnologyEuropeFinancialPharmaceuticalRegulation

Islet Sciences closes stock acquisition of diabetes drug developer DiaKine

26-03-2012

New York. USA-based biotech company Islet Sciences (OTC.BB: ISLT),said Friday that it has closed its…

BiotechnologyDiabetesDiaKine TherapeuticsIslet SciencesMergers & Acquisitions

Shaking-up gene delivery in the neurodegenerative disease world

25-03-2012

San Diego-based Ceregene, which is developing a novel neurotrophic factor gene therapy delivery via adeno-associated…

BiotechnologyCeregeneNeurologicalResearch

Anaphore buys Chinese firm RuiYi for GPCR biologics platform

23-03-2012

Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

US FDA ties up another Biosimilars loose end

23-03-2012

The US Food and Drug Administration issuance of three long-awaited and highly anticipated draft biosimilar…

BiotechnologyGenericsNorth AmericaRegulation

US TREAT Act poised to revolutionize the biotechnology industry

22-03-2012

In recent years, smaller biotechnology companies have received less funding from venture capitalists…

BiotechnologyFinancialLegalNorth AmericaRegulation

NicOx takes option to buy UK ophthalmic company

22-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) has entered into an agreement to acquire 11.8%…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

ABPI and BIA see UK Budget statement as helping the sectors

22-03-2012

The Budget statement yesterday by UK Chancellor of the Exchequer George Osborne was broadly supported…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Index Ventures debuts new Life Sciences Fund, partnered by GSK and J&J

21-03-2012

Index Ventures says it has launched its first fund solely dedicated to making investments in the life…

BiotechnologyFinancialGlaxoSmithKlineIndex VenturesJanssenJohnson & JohnsonPharmaceutical

Ablynx extends Nanobody deal with Boehringer

21-03-2012

Belgian drug developer Ablynx (Euronext Brussels: ABLX) yesterday announced a two-year extension of the…

AblynxBiotechnologyBoehringer IngelheimImmunologicalsLicensingOncologyPharmaceuticalRespiratory and Pulmonary

New IP legislation will encourage medical research in Australia, says trade group

20-03-2012

New legislation overhauling the Australian patent system will encourage medical research and bring Australia…

Asia-PacificBiotechnologyLegalPatentsPharmaceuticalResearch

Halo Thera lead candidate for Duchenne ready for the clinic

20-03-2012

Privately-held US clinical stage biopharma firm Halo Therapeutic says that an independent review of its…

BiotechnologyHalo TherapeuticshalofuginonePharmaceuticalRare diseasesResearch

Grifols acquires 51% stake in Araclon Biotech

19-03-2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

1950 to 1974 of 2289 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top